Rituximab offered no therapeutic benefit in Graves' ophthalmopathy.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      The article discusses a research study which found that rituximab offered no therapeutic benefit among patients with active moderate-to severe Graves' ophthalmopathy, presented at the Annual Meeting of the American Thyroid Association held in San Juan, Puerto Rico on October 16-20, 2013.